603669 靈康藥業
按盤價 
4.720 +0.040 (+0.855%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.739 | -14.668 | -15.104 | 4.485 | 11.460 |
| 總資產報酬率 ROA (%) | -1.032 | -8.707 | -8.964 | 2.520 | 6.915 |
| 投入資產回報率 ROIC (%) | -1.081 | -9.094 | -9.260 | 2.622 | 6.384 | 邊際利潤分析 |
| 銷售毛利率 (%) | 57.054 | 46.672 | 67.809 | 79.376 | 83.941 |
| 營業利潤率 (%) | -22.389 | -75.690 | -65.226 | 9.608 | 18.057 |
| 息稅前利潤/營業總收入 (%) | -21.490 | -76.447 | -65.670 | 10.385 | 18.303 |
| 淨利潤/營業總收入 (%) | -20.871 | -76.967 | -67.711 | 8.902 | 15.991 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 110.583 | 103.963 | 89.066 | 48.031 | 55.729 |
| 價值變動淨收益/利潤總額(%) | 38.655 | 9.628 | 4.300 | 23.916 | 0.272 |
| 營業外收支淨額/利潤總額(%) | -6.320 | 1.308 | 0.069 | -0.920 | -0.830 | 償債能力分析 |
| 流動比率 (X) | 6.717 | 3.626 | 3.743 | 2.756 | 2.787 |
| 速動比率 (X) | 6.191 | 3.393 | 3.581 | 2.676 | 2.692 |
| 資產負債率 (%) | 38.419 | 42.690 | 38.849 | 41.980 | 45.517 |
| 帶息債務/全部投入資本 (%) | 34.825 | 39.190 | 36.010 | 39.555 | -- |
| 股東權益/帶息債務 (%) | 184.956 | 153.346 | 176.783 | 150.667 | 135.628 |
| 股東權益/負債合計 (%) | 160.288 | 134.249 | 157.405 | 138.208 | 119.699 |
| 利息保障倍數 (X) | 49.727 | -310.910 | 164.745 | 12.006 | 46.310 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.416 | 143.506 | 134.245 | 71.707 | 0.000 |
| 存貨周轉天數 (天) | 157.095 | 181.612 | 194.865 | 142.329 | 0.000 |
| 備註： | 即時報價更新時間為 28/06/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
